Aim ImmunotechAIM
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 33 institutions reported holding Aim Immunotech Inc. (AIM) in their 13F filings, down 3 from Q2 2024. 4 opened new positions and 7 sold out. The largest holders were Armistice Capital, LLC ($1.2M), Vanguard Group Inc. ($537K) and BlackRock, Inc. ($189K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Aim Immunotech Inc.
- CUSIP
- 00901B105
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $12K |
| Exits | 7 | $56K |
All 13F filers, Q2 2024 → Q3 2024: 831,979 shares bought and 263,299 shares sold, net +568,680 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Armistice Capital, LLC | 0.03% | Add +6.2% | 4,330,000 | $1.2M |
| Vanguard Group Inc. | 0.00% | No change | 1,988,704 | $537K |
| BlackRock, Inc. | 0.00% | — | 698,267 | $189K |
| Geode Capital Management, LLC | 0.00% | Add +15.7% | 464,016 | $125K |
| Citadel Advisors | 0.00% | Add +367.0% | 457,767 | $124K |
| Renaissance Technologies | 0.00% | Add +6.3% | 243,208 | $66K |
| State Street Corp. | 0.00% | No change | 173,103 | $47K |
| Verition Fund Management LLC | 0.00% | No change | 153,000 | $41K |
| Virtu Financial LLC | 0.00% | Add +81.7% | 102,129 | $28K |
| Northern Trust Corp. | 0.00% | No change | 85,119 | $23K |
| Morgan Stanley | 0.00% | Reduce -1.2% | 84,320 | $23K |
| XTX Topco Ltd | 0.00% | Add +353.6% | 65,897 | $18K |
| SeaCrest Wealth Management, LLC | 0.00% | No change | 35,063 | $9K |
| HRT Financial LP | 0.00% | New | 34,744 | $9K |
| Captrust Financial Advisors | 0.00% | No change | 20,000 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -42.9% | 15,261 | $4K |
| Community Bank, N.A. | 0.00% | No change | 13,226 | $3K |
| D.B. Root & Company, LLC | 0.00% | No change | 12,050 | $3K |
| Traynor Capital Management, Inc. | 0.00% | No change | 11,777 | $3K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -87.6% | 11,000 | $3K |
| Corient Private Wealth LP | 0.00% | New | 10,000 | $3K |
| Hoey Investments, Inc. | 0.00% | No change | 1,000 | $373 |
| Osaic Holdings, Inc. | 0.00% | No change | 1,000 | $270 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 600 | $162 |
| Bank of America Corp. | 0.00% | Add +9.7% | 431 | $116 |
| Wells Fargo & Company | 0.00% | Reduce -65.1% | 400 | $108 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 170 | $43 |
| Farther Finance Advisors, LLC | 0.00% | New | 150 | $41 |
| JPMorgan Chase & Co. | 0.00% | Add +15.4% | 135 | $37 |
| Huntington National Bank | 0.00% | No change | 57 | $15 |
| UBS Group AG | 0.00% | Reduce -99.9% | 21 | $6 |
| Cwm, LLC | 0.00% | No change | 1 | $0 |
| NewEdge Advisors, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is AIM's weight in each manager's 13F, not the share of Aim Immunotech Inc. the manager owns.